Gilead and Arcellx reported promising data for their CAR-T therapy anito-cel at the annual American Society of Hematology meeting. Read more
Stat - Dec 07
A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T cell therapy, while others see their cancer return sooner. Read more
Medical News - Nov 13
Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of current therapies against the disease. Read more
Medical News - Sep 25
The treatment removed, altered and returned cells to fight cancer all in one patient visit. Read more
Spectrum News 1 | Buffalo - Sep 22
Researchers at Dana-Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. Read more
Medical News - Aug 08
